Another study involving human cancer patients, looked at pre-operative biopsy and post-irradiation specimens in 98 patients of rectal cancer and found that increased GHR expression was associated with poor response to IR treatment and postulated that GHR-antagonism can actually improve rectal cancer sensitivity to IR therapy[186]. The gene discussed is GHR; the disease is rectal cancer.